In a press release, Lilly announced that in its latest trial comparing its medication, Zepbound, to Wegovy, made by Novo ...

Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo ...

Shares of Eli Lilly climbed early Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss ...

Eli Lilly’s weight loss drug, Zepbound, has been shown to lead to more significant weight loss than Novo Nordisk’s Wegovy, ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...

The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible ...

Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made available to around 220,000 people in the country via the state health ...

An open- label Phase III trial showed that participants using Zepbound saw 47% greater relative weight loss compared to ...

Thanks to social media saturation and crafty supplement marketing, young boys are pushing weights and chugging shakes to get ...

From breaking out of local clubs to touring with Jethro Tull and attracting guest spots from David Bowie and Peter Sellers, ...

The effort to remove President Yoon Suk Yeol reflected fury over his declaration of martial law. He lifted the order within hours after it incited protests. Members of South Korea’s opposition ...

Despite following all recommended screenings, Regina Barzilay, PhD, was diagnosed with breast cancer. Discover how this Health Hero’s experience led to an AI system that improves breast cancer ...